by Sandra Annetzberger | Sep 20, 2021 | Uncategorized
The CARAMBA Consortium published an article about the CARAMBA project. Within the article you can find information on CART cell technology and on the CARAMBA project. Supplemented by figures, the technology of virus-free gene transfer using the Spleeping Beauty...
by Sandra Annetzberger | Jul 2, 2021 | Uncategorized
In 2020, the two EU-projects CARAMBA and EURE-CART jointly organized a regulatory workshop on CAR-T cell development. With the EURE-CART project coming to an end in June 2021, the EURE-CART Consortium has now published a White Paper on CAR-T cell therapy development....
by Sandra Annetzberger | Mar 11, 2021 | Uncategorized
CARAMBA AT THE 3RD EUROPEAN CAR-T MEETING After two successful European CAR-T meetings in 2019 and 2020, the CARAMBA project took again part in the 3rd European CAR-T workshop (4-6 February 2021), this time virtually due to the current Covid-19 situation. The meeting...
by Sandra Annetzberger | Feb 11, 2021 | Uncategorized
CARAMBA consortium partner Myeloma Patients Europe (MPE) has issued an information sheet about the CARAMBA clinical trial which will take place in four centres of excellence in myeloma clinical care and research: University Hospital Würzburg (Germany), Ospedale San...
by Sabine Possmann | Apr 2, 2020 | Uncategorized
Jointly organized by the H2020 projects EURE-CART (European Endeavour for Chimeric Antigen Receptor Therapies) & CARAMBA (SLAMF7-CAR T for Immunotherapy of Multiple Myeloma) 29 – 30 January 2020 Meeting Report EXECUTIVE SUMMARY On 29th and 30th January 2020, the...
by Sabine Possmann | Jan 7, 2020 | Uncategorized
With the first approvals of the CAR T cell treatments in Europe, a partial victory in the fight against hematological malignancies was achieved. However, the route from bench to bedside poses several challenges, demanding for a European-wide harmonization process....